ES2195382T3 - Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos. - Google Patents

Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.

Info

Publication number
ES2195382T3
ES2195382T3 ES98942786T ES98942786T ES2195382T3 ES 2195382 T3 ES2195382 T3 ES 2195382T3 ES 98942786 T ES98942786 T ES 98942786T ES 98942786 T ES98942786 T ES 98942786T ES 2195382 T3 ES2195382 T3 ES 2195382T3
Authority
ES
Spain
Prior art keywords
compounds
alkyl
indolcarboxyl
pharmaceutical
chr3r4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98942786T
Other languages
English (en)
Inventor
Bruno Bernard
Catherine Gerst
Jean-Baptiste Galey
Maria Dalko
Patrick Pichaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2195382T3 publication Critical patent/ES2195382T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION COMO PRINCIPIO ACTIVO, EN UN MEDIO FISIOLOGICAMENTE ACEPTABLE, EN UNA COMPOSICION, DE UNA CANTIDAD EFICAZ DE AL MENOS UN COMPUESTO DE LA FAMILIA DE LOS INDOLCARBOXILICOS, DESTINANDOSE ESTE COMPUESTOS O ESTAS COMPOSICIONES A TRATAR LOS TRASTORNOS LIGADOS A LA SOBREACTIVIDAD DE LA 5 AL - REDUCTASA. ESTOS COMPUESTOS O LAS COMPOSICIONES QUE LOS CONTIENEN SE DESTINAN MAS EN PARTICULAR A TRATAR LOS TRASTORNOS ANDROGENODEPENDIENTES COMO POR EJEMPLO LA SEBORREA Y/O EL ACNE Y/O EL HIRSUTISMO Y/O LA ALOPECIA ANDROGENICA. LA INVENCION SE REFIERE TAMBIEN A NUEVOS COMPUESTOS DE LA FAMILIA DE LOS INDO - CARBOXILICOS ASI COMO A LAS COMPOSICIONES QUE LOS CONTIENEN.
ES98942786T 1997-09-05 1998-08-26 Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos. Expired - Lifetime ES2195382T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9711076A FR2768146B1 (fr) 1997-09-05 1997-09-05 Nouveaux composes de la famille des indole-carboxyliques et leur utilisation

Publications (1)

Publication Number Publication Date
ES2195382T3 true ES2195382T3 (es) 2003-12-01

Family

ID=9510808

Family Applications (2)

Application Number Title Priority Date Filing Date
ES03000188T Expired - Lifetime ES2268169T3 (es) 1997-09-05 1998-08-26 Compuestos indol-carboxilicos y su utilizacion como compuestos farmaceuticos.
ES98942786T Expired - Lifetime ES2195382T3 (es) 1997-09-05 1998-08-26 Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES03000188T Expired - Lifetime ES2268169T3 (es) 1997-09-05 1998-08-26 Compuestos indol-carboxilicos y su utilizacion como compuestos farmaceuticos.

Country Status (10)

Country Link
US (2) US6448285B1 (es)
EP (2) EP1302460B1 (es)
JP (2) JP4090515B2 (es)
AT (2) ATE334962T1 (es)
AU (1) AU9079198A (es)
CA (2) CA2271085C (es)
DE (2) DE69812073T2 (es)
ES (2) ES2268169T3 (es)
FR (1) FR2768146B1 (es)
WO (1) WO1999012905A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495538B2 (en) * 1999-06-23 2002-12-17 Zinc Therapeutics, Canada Inc. Zinc ionophores as therapeutic agents
FR2796279B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
AU2002357003A1 (en) * 2001-12-28 2003-07-24 Guilford Pharmaceuticals Inc. Indoles as naaladase inhibitors
AU2003214462A1 (en) 2002-04-03 2003-10-13 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity
US7041636B1 (en) 2004-01-22 2006-05-09 Benton Melody M Composition for counteracting hair loss
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
US20080063673A1 (en) * 2006-09-13 2008-03-13 Akridge Robert E Method and kit for treatment/prevention of hair loss
US20080160509A1 (en) * 2006-09-13 2008-07-03 Pacific Bioscience Laboratories, Inc. Assays for predicting and assessing predisposition to male pattern baldness
WO2008042571A2 (en) * 2006-09-29 2008-04-10 Smithkline Beecham Corporation Substituted indole compounds
KR20090106539A (ko) 2006-12-22 2009-10-09 쉐링 코포레이션 Ｈｃｖ 및 관련 바이러스 감염을 치료 또는 예방하기 위한 4,5-환 환상 인돌 유도체
EP2081922B1 (en) 2006-12-22 2012-02-01 Schering Corporation 5,6-Ring annulated indole derivatives and use thereof
AU2007339382B2 (en) 2006-12-22 2013-05-02 Merck Sharp & Dohme Llc 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
KR20090001013A (ko) * 2007-06-29 2009-01-08 주식회사 웰스킨 인돌-3-알킬카복실산을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
MX2010002317A (es) 2007-08-29 2010-03-22 Schering Corp Derivados de indol sustituidos y metodos para su utilizacion.
AU2008295476B2 (en) 2007-08-29 2013-08-01 Merck Sharp & Dohme Corp. 2, 3-Substituted Indole Derivatives for treating viral infections
EP2195317B1 (en) 2007-08-29 2012-01-18 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
CN102099351A (zh) 2007-11-16 2011-06-15 先灵公司 3-杂环取代的吲哚衍生物及其使用方法
WO2009064852A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-aminosulfonyl substituted indole derivatives and methods of use thereof
JP5580814B2 (ja) 2008-06-13 2014-08-27 メルク・シャープ・アンド・ドーム・コーポレーション ３環式インドール誘導体およびその使用方法
WO2010143803A2 (en) * 2009-06-08 2010-12-16 Industry Foundation Of Chonnam National University New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
FR2953722B1 (fr) 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
KR101213495B1 (ko) * 2010-06-03 2013-01-14 삼성디스플레이 주식회사 유기 발광 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB359876A (en) 1930-05-20 1931-10-29 British Thomson Houston Co Ltd Improvements in and relating to polyphase thermionic generators
BE794483A (fr) * 1972-01-26 1973-07-24 Boehringer Mannheim Gmbh Derives de l'acide indol-carbonique a effet hypoglycemiant et procedes pour leur preparation
LU86347A1 (fr) * 1986-03-06 1987-11-11 Oreal Compositions pour la coloration de la peau a base de derives d'indole
FR2686345A1 (fr) * 1992-01-16 1993-07-23 Oreal Produit a base de particules minerales colorees comportant un pigment melanique, son procede de preparation et son utilisation en cosmetique.
FR2689898B1 (fr) * 1992-04-08 1994-06-10 Oreal Pigments comportant un support inorganique et le produit de reaction d'un derive indolique et d'un derive quinonique, leur procede de preparation et leur utilisation en cosmetique.
JPH07507574A (ja) * 1993-04-05 1995-08-24 藤沢薬品工業株式会社 テストステロン５α−レダクターゼ阻害剤用インドール誘導体
DE4314317A1 (de) 1993-04-30 1994-11-03 Henkel Kgaa Isatinhaltige Mittel zum Färben von keratinhaltigen Fasern
WO1997035572A1 (en) * 1996-03-28 1997-10-02 Smithkline Beecham Corporation Carboxylic acid indole inhibitors of chemokines
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
ES2268169T3 (es) 2007-03-16
EP0964852A1 (fr) 1999-12-22
WO1999012905A1 (fr) 1999-03-18
ATE334962T1 (de) 2006-08-15
US20030050325A1 (en) 2003-03-13
DE69812073T2 (de) 2003-09-25
CA2569685A1 (fr) 1999-03-18
CA2271085C (fr) 2007-04-17
JP4090515B2 (ja) 2008-05-28
US6596753B2 (en) 2003-07-22
CA2271085A1 (fr) 1999-03-18
EP0964852B1 (fr) 2003-03-12
US6448285B1 (en) 2002-09-10
EP1302460A1 (fr) 2003-04-16
AU9079198A (en) 1999-03-29
FR2768146B1 (fr) 2000-05-05
DE69835460T2 (de) 2007-07-26
JP2004035566A (ja) 2004-02-05
EP1302460B1 (fr) 2006-08-02
ATE234283T1 (de) 2003-03-15
DE69812073D1 (de) 2003-04-17
JP2000508352A (ja) 2000-07-04
DE69835460D1 (de) 2006-09-14
FR2768146A1 (fr) 1999-03-12

Similar Documents

Publication Publication Date Title
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
EE03139B1 (et) Piperasiiniderivaadid, nende kasutamine ja farmatseutiline kompositsioon
SE8406585D0 (sv) Benzoic acid derivatives
DK0628311T3 (da) Xanthinderivater som antidepressive midler
NO20015446D0 (no) Kinolin-derivater som inhibitorer for MEK-enzymer
FR2687543B1 (fr) Utilisation de derives du triazole pour la protection du bois.
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
ATE9474T1 (de) Cephalosporinverbindungen und ihre herstellung.
DK190188A (da) Aromatiske derivater og fremgangsmaade til fremstilling deraf samt deres anvendelse som antimikrobielle midler
CO4970719A1 (es) Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
NO981814D0 (no) Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas÷ytiske sammensetninger som inneholder dem
DK0615971T3 (da) 5-(Piperazinylalkyl)-1,5-benzothiazepinoner, der kan anvendes som calciumantagonister
PL352172A1 (en) Derivatives of n-alkoxyalkylo-n,n-dialkyloamine or salts thereof and the agents containing these compounds used in treatment of neurodegenerative diseases
FI962768A0 (fi) N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja
ATE69802T1 (de) Ungesaettigte derivate von methylendianilin.
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
NO963854D0 (no) Okulart spenningsnedsettende middel
AR010550A1 (es) Derivados de cefalosporina, su uso, proceso para fabricarlos y preparaciones farmaceuticas que los contienen.
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.
GB1065965A (en) Dibenzocyclooctenes
ECSP961980A (es) Compuestos de quinolina y quinazolina utiles en terapia
NO976101D0 (no) Nye ellipticinforbindelser, en fremgangsmåte ved deres fremstilling, samt farmasöytiske blandinger som inneholder dem
HUP0202237A2 (hu) Amin, módosított pszeudomicin vegyületek, azokat tartalmazó gyógyászati készítmény és alkalmazásuk